Celtic Biotech Iowa is developing novel therapeutic products for the treatment of cancers and pain in humans. Derived from naturally specialized receptor-binding proteins, these products have the potential to reduce treatment costs, increase survivability, and improve the quality of life for cancer patients. Biotechnologies
Crotoxin Crotamine (being developed in cooperation with Emory University)
Memcine Pharmaceuticals, Inc.
Memcine Pharmaceuticals is an early-stage biotech company focused on enhancing vaccine efficacy to improve human and animal health globally. Memcine’s Immunoplex™ technology platform uses the body’s naturally occurring targeting system to deliver vaccine components. The current portfolio of potential infectious disease vaccine targets includes influenza, HepB, and Ebola. Memcine Pharmaceuticals has also conducted pre-clinical experiments in a mouse model of breast cancer, where the vaccine technology showed considerable promise as a therapeutic treatment. Biotechnology
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.